Covered recipient · General Payments record
ROBERT E CARO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,516.07
- Reported across 208 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $479.50 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $149.55 | 9 |
| Lilly USA, LLC | $78.47 | 4 |
| ABBVIE INC. | $67.47 | 4 |
| Amgen Inc. | $30.16 | 2 |
| Corcept Therapeutics | $27.31 | 1 |
| GlaxoSmithKline, LLC. | $26.91 | 1 |
| DEXCOM, INC. | $25.51 | 1 |
| Phathom Pharmaceuticals, Inc. | $21.34 | 1 |
| PFIZER INC. | $19.87 | 1 |
| Acerta Pharma LLC | $19.20 | 1 |
| Astellas Pharma US Inc | $13.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020212022
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.14 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103418521 | CMS |
| ABBVIE INC. | $14.89 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103418523 | CMS |
| ABBVIE INC. | $20.17 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103418525 | CMS |
| ABBVIE INC. | $16.27 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103418527 | CMS |
| Amgen Inc. | $15.95 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117521279 | CMS |
| Amgen Inc. | $14.21 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117521281 | CMS |
| Astellas Pharma US Inc | $13.71 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139297304 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.20 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105592190 | CMS |
| Corcept Therapeutics | $27.31 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117752724 | CMS |
| Dexcom, Inc. | $25.51 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153331257 | CMS |
| GlaxoSmithKline, LLC. | $26.91 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116473355 | CMS |
| Lilly USA, LLC | $25.41 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135336353 | CMS |
| Lilly USA, LLC | $20.29 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135368430 | CMS |
| Lilly USA, LLC | $15.10 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135393443 | CMS |
| Lilly USA, LLC | $17.67 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135359456 | CMS |
| Novo Nordisk Inc | $12.78 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096793743 | CMS |
| Novo Nordisk Inc | $10.60 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096606897 | CMS |
| Novo Nordisk Inc | $9.63 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097415943 | CMS |
| Novo Nordisk Inc | $19.43 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097283377 | CMS |
| Novo Nordisk Inc | $13.30 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096829063 | CMS |
| Novo Nordisk Inc | $25.35 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097138059 | CMS |
| Novo Nordisk Inc | $19.36 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096924706 | CMS |
| Novo Nordisk Inc | $18.29 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097197000 | CMS |
| Novo Nordisk Inc | $20.81 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097296655 | CMS |
| PFIZER INC. | $19.87 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131793483 | CMS |
| Phathom Pharmaceuticals, Inc. | $21.34 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151045942 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.